Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies
Coralea Stephanou(Agruicultural Research Institute), Petros Kountouris(Cyprus Institute of Neurology and Genetics), Anna Minaidou(Cyprus Institute of Neurology and Genetics), Marina Kleanthous(Cyprus Institute of Neurology and Genetics), Stella Tamana(Fundación Instituto Leloir), Panayiota Papasavva(Cyprus Institute of Neurology and Genetics)
Cited by 16
Related Papers
Critical assessment of protein intrinsic disorder prediction
|Nature Methods|2021|362
Prediction of backbone dihedral angles and protein secondary structure using support vector machines
|BMC Bioinformatics|2009|59
Next generation sequencing of SNPs for non-invasive prenatal diagnosis: challenges and feasibility as illustrated by an application to β-thalassaemia
|European Journal of Human Genetics|2013|55
The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study
|Scientific Reports|2016|48